Nektar Therapeutics
(NASDAQ : NKTR)

( )
NKTR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.58%62.991.0%$429.08m
AMGNAmgen, Inc. 0.00%237.601.3%$415.39m
BIIBBiogen, Inc. 0.46%288.501.4%$364.64m
ILMNIllumina, Inc. -0.10%328.003.5%$323.24m
VRTXVertex Pharmaceuticals, Inc. -0.78%233.991.9%$273.36m
REGNRegeneron Pharmaceuticals, Inc. 0.51%365.552.6%$218.36m
EXASEXACT Sciences Corp. 0.82%86.6024.0%$198.72m
ITCIIntra-Cellular Therapies, Inc. 0.28%25.509.0%$173.94m
ALXNAlexion Pharmaceuticals, Inc. -0.23%113.012.0%$173.06m
INCYIncyte Corp. -2.30%78.652.5%$135.12m
SRPTSarepta Therapeutics, Inc. -1.55%121.0814.6%$130.98m
AAgilent Technologies, Inc. -0.01%89.611.6%$120.05m
BMRNBioMarin Pharmaceutical, Inc. -0.82%87.554.3%$106.16m
BLUEbluebird bio, Inc. -2.26%95.8214.2%$95.27m
SGENSeattle Genetics, Inc. -0.30%108.676.1%$90.33m

Company Profile

Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The company focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.